CCEM Talks: Dr. Hala Zreiqat
Engineering regeneration: nanostructured personalised biomaterials for musculoskeletal repair and stem cell rejuvenation in ageing
- https://multiscale.upc.edu/en/events/copy4_of_seminar-prof-upal-roy
- CCEM Talks: Dr. Hala Zreiqat
- 2026-06-08T12:00:00+02:00
- 2026-06-08T13:00:00+02:00
- Engineering regeneration: nanostructured personalised biomaterials for musculoskeletal repair and stem cell rejuvenation in ageing
Jun 08, 2026 from 12:00 PM to 01:00 PM (Europe/Madrid / UTC200)
Prof. Hala Zreiqat (University of Sydney, Australia) is an internationally recognized leader in the fields of biomaterials and regenerative medicine, and a pioneer in the design of advanced synthetic platforms for tissue engineering. As a leading figure in bridging the divide between materials science and senescent biology, her work is redefining how personalized, nanostructured scaffolds can overcome the hostile microenvironments of the aging body to actively stimulate musculoskeletal repair.
In this CCEM Talk, titled "Engineering regeneration: nanostructured personalised biomaterials for musculoskeletal repair and stem cell rejuvenation in ageing," it will be explored how the critical challenge of repairing major bone defects in an aging population can be overcome by shifting away from conventional grafts toward smart, integrated engineering approaches. Prof. Zreiqat will present how hardware and manufacturing innovations, including patented 3D and nanoscale printing technologies, allow for the creation of bioceramic scaffolds that offer tailored mechanical, structural, and antibacterial support. Crucially, the session will illustrate how merging advanced materials design with targeted anti-senescence strategies can rejuvenate and boost the resilience of both native and transplanted stem cells.
This seminar represents a unique opportunity to learn firsthand about the latest advances at the interface of advanced materials characterization, cellular biology, and the future of highly translational musculoskeletal and soft tissue clinical therapies.
Share: